Octreotide and the secretory effects of advanced cancer.
Harvey
F M
FM
Dunlop
R J
RJ
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007419:Intestinal Secretions; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010166:Palliative Care; D012004:Rectal Neoplasms / Q000150:complications; D012811:Sigmoid Neoplasms / Q000150:complications
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide